How the Spain Viral Vectors and Plasmid DNA Manufacturing Market is Transforming Healthcare
The Spain viral vectors plasmid DNA manufacturing market is on the verge of a significant transformation, poised to reach an estimated value of $17.38 million by 2035. This remarkable trajectory reflects a compound annual growth rate (CAGR) of 11.99%, driven by the escalating demand for advanced gene therapies and vaccines. Recent advancements in biotechnology coupled with a favorable...
0 Commenti 0 Condivisioni 5 Visualizzazioni